$TLRY

Tilray Brands (NASDAQ: TLRY) reported fiscal 2026 net revenue of $915.5 million, up 11% year over year, with record results. The article says growth has relied mainly on acquisitions and international expansion, making organic performance harder to gauge. It cites high cash burn, including $69 million used for operating activities and $56 million in investing outflows, and notes TLRY shares down about 97% over five years.

Tilray Brands said in its annual report filed July 28 that Terrapin Beer Co. will stop brewing at its Athens, Georgia facility on Sept. 25, 2026 as part of “Project 420” restructuring. The taproom, beer garden, warehouse, and repack operations will continue, while brewing will shift offsite. Redhook, Atwater, Hop Valley, and Revolver are also cited in consolidation.

Gendel Mitchell (Global General Counsel) purchased 2,500 shares of Tilray Brands, Inc. (TLRY) at $4.43 on 2026-08-06.

Tilray Brands reported Q4 sales of US$281.71 million and full-year sales of US$915.45 million for the year ended May 31, 2026, with a substantially smaller net loss than the prior year. The company also filed a US$47.69 million shelf registration for 11,355,231 common shares tied to its ESOP. Management said at-the-market equity proceeds may fund acquisitions, including deals like BrewDog.

Merton Carl A (Chief Financial Officer) purchased 10,000 shares of Tilray Brands, Inc. (TLRY) at $4.62 on 2026-08-04.

FALTISCHEK DENISE M (Chief Strategy Officer) purchased 2,500 shares of Tilray Brands, Inc. (TLRY) at $4.78 on 2026-08-03.

U.S. stock index futures fell overnight after the U.S. launched “self-defense strikes” on Iran following the shootdown of American helicopters near the Strait of Hormuz, according to U.S. Central Command. Dow futures -0.05%, S&P 500 futures -0.11%, Nasdaq 100 futures -0.21%. ETFs SPY, QQQ and DIA were lower; TLT slightly down. Focus includes ORCL earnings and CPI; SMCI, TLRY, DKNG, CBRL moved on company updates.

Tilray Brands (TLRY) reported fiscal 2026 results for the year ended May 31. Net revenue rose 11% to $915.5M. The largest growth came from its distribution segment, up 21% to over $327M, while beverages grew about 6%. Tilray posted an operating loss of $63M, and CEO Irwin Simon cited expansion of its Europe medical cannabis and pharma distribution platform.

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022.

Tilray Brands stock continued its strong downtrend and is hovering at its lowest level since June last year. TLRY has slumped by 57% this year, mirroring the performance of other cannabis stocks like Green Thumb Industries, Truelive Cannabis, and Curaleaf. So, is it safe to buy the Tilray stock dip? Why Tilray Brands stock has plunged The TLRY stock has been in a strong sell-off this year as investors wait for more details on cannabis reclassification in the United States.